{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/promoting-patient-and-site-centricity-neurodegenerative-disease-clinical-trials#webpage",
"url": "https://www.fortrea.com/insights/promoting-patient-and-site-centricity-neurodegenerative-disease-clinical-trials",
"name": "Promoting patient and site centricity in neurodegenerative disease clinical trials",
"description": "Explore this Fortrea white paper on patient- and site-centric strategies in neurodegenerative disease clinical trials and discover how neuroscience clinical development programs are evolving to better support patients, caregivers, and research sites across complex neurological studies. The white paper examines key challenges in neurodegenerative disease clinical trials, including patient recruitment and retention, caregiver burden, biomarker collection strategies, cognitive assessments, decentralized clinical trial approaches, and site engagement planning in disorders such as Alzheimer’s disease, Parkinson’s disease, ALS, and frontotemporal dementia. Learn how patient-centric neuroscience research models, caregiver-focused support strategies, digital biomarkers, remote monitoring technologies, wearable devices, and site advisory board approaches can help reduce patient burden, improve trial accessibility, strengthen operational efficiency, enhance patient participation and retention, and support more effective execution of neurodegenerative disease clinical research programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Promoting patient and site centricity in neurodegenerative disease clinical trials",
"item": "https://www.fortrea.com/insights/promoting-patient-and-site-centricity-neurodegenerative-disease-clinical-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/promoting-patient-and-site-centricity-neurodegenerative-disease-clinical-trials#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/promoting-patient-and-site-centricity-neurodegenerative-disease-clinical-trials#webpage"
},
"headline": "Patient- & Site-Centric Strategies in Neurodegenerative Disease Clinical Trials | Fortrea White Paper",
"description": "Explore this Fortrea white paper on patient- and site-centric strategies in neurodegenerative disease clinical trials and discover how neuroscience clinical development programs are evolving to better support patients, caregivers, and research sites across complex neurological studies. The white paper examines key challenges in neurodegenerative disease clinical trials, including patient recruitment and retention, caregiver burden, biomarker collection strategies, cognitive assessments, decentralized clinical trial approaches, and site engagement planning in disorders such as Alzheimer’s disease, Parkinson’s disease, ALS, and frontotemporal dementia. Learn how patient-centric neuroscience research models, caregiver-focused support strategies, digital biomarkers, remote monitoring technologies, wearable devices, and site advisory board approaches can help reduce patient burden, improve trial accessibility, strengthen operational efficiency, enhance patient participation and retention, and support more effective execution of neurodegenerative disease clinical research programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2024-10/GettyImages-1343468128.webp"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-14",
"dateModified": "2024-10-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/WP_0057_Neuro%20Patient%20Centric_0624_HiRes.pdf",
"encodingFormat": "application/pdf"
}
}
]
}